People with advanced head and neck squamous cell carcinoma and the KRAS-variant inherited genetic mutation have significantly improved survival when given a short course of the drug cetuximab in combination with standard chemotherapy and radiation, research has found.
from Top Health News – ScienceDaily http://ift.tt/2ikOFrX
from Tumblr http://ift.tt/2ikJubA
No comments:
Post a Comment